Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

IMPORTANCE: Adjuvant chemotherapy in patients with stage III colon cancer prevents recurrence by eradicating minimal residual disease. However, which patients remain at high risk of recurrence after completing standard adjuvant treatment cannot currently be determined. Postsurgical circulating tumor...

Full description

Saved in:
Bibliographic Details
Published in:JAMA Oncol
Main Authors: Tie, Jeanne, Cohen, Joshua D., Wang, Yuxuan, Christie, Michael, Simons, Koen, Lee, Margaret, Wong, Rachel, Kosmider, Suzanne, Ananda, Sumitra, McKendrick, Joseph, Lee, Belinda, Cho, Jin Hee, Faragher, Ian, Jones, Ian T., Ptak, Janine, Schaeffer, Mary J., Silliman, Natalie, Dobbyn, Lisa, Li, Lu, Tomasetti, Cristian, Papadopoulos, Nicholas, Kinzler, Kenneth W., Vogelstein, Bert, Gibbs, Peter
Format: Artigo
Language:Inglês
Published: American Medical Association 2019
Subjects:
Original Investigation
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6802034/
https://ncbi.nlm.nih.gov/pubmed/31621801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.3616
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items